Concepedia

Lauren Fischer

LF

Statistics

Publications

6

Citations

297

H-Index

6

Active since

2013

Affiliations

Seqirus (United States)(Current)

Veracyte (United States)

Lauren Fischer is an author at Seqirus (United States) specializing in immunology, vaccine effectiveness, and age-specific vaccine effectiveness.

Publications per year

2013–2024

6

Publications

6

The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Marina Vivarelli, Jonathan Barratt, Laurence H. Beck et al. · Kidney International · 2024 · 125 citations · Full text

, , +17

Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons

Constantina Boikos, Lauren Fischer, Dan O’Brien et al. · Clinical Infectious Diseases · 2021 · 54 citations · Full text

, , +17

Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States

Constantina Boikos, Lauren Fischer, Dan O’Brien et al. · Clinical Infectious Diseases · 2021 · 49 citations · Full text

, , +16

JAMA Internal Medicine

Phil Fontanarosa, Annette Flanagin, Paula Glitman et al. · JAMA Internal Medicine · 2013 · 32 citations · Full text

, , +7

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season

Mahrukh Imran, Joan Puig‐Barberà, Justin R. Ortiz et al. · Open Forum Infectious Diseases · 2022 · 19 citations · Full text

, , +17

1–5 of 6